Izun Pharma Ltd.

Biopharmaceutical company developing non-steroidal topical oral anti-inflammatory therapies and oncology support products.

Biotechnology
Active
Jerusalem, Israel Founded 2000
Website ↗
Last updated 2026-08-18
Total raised
$9.3M
Stage
Founded
2000
Headcount
HQ
Jerusalem, Israel
Sector
Biotechnology

About

Izun Pharma is an emerging biopharmaceutical company with a product portfolio of powerful non-steroidal topical oral anti-inflammatory therapies with superior efficacy and safety to current periodontal treatments. The company aims to develop innovative topical drugs and products based on botanical sources addressing major, under-served markets. Izun Pharmaceuticals is also focused on oncology support, developing products that enable more effective cancer therapy and improve the quality of life for cancer patients. The company's core technology utilizes naturally derived pharmaceutical actives for the treatment of oral disease with inflammatory components.

Funding history · 3 rounds · $9.3M total

2022-10
Secondary Undisclosed
2014-11
A Round $5.2M
2012-06
Seed $4.1M

Team · 5

William Levine
Founder · Founder & Chief Scientific Officer
Gabriel Nussbaum
Director of Scientific Affairs
Leslie Kraus
CFO
Shimon Lecht
Chief R&D Officer
Oscar Straus Schafer
Chairman

Sectors & technology

Primary sector
Biotechnology
Target customers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)